EUVIMEDEUVIMED entdecken
Crossref

Immuno-virological and Clinical Follow-up of Persons With HIV-2 (PWHIV-2) Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate (BIC/FTC/TAF): A Retrospective Study

Véronique Joly iD, Valentine M Ferré, Quentin Le Hingrat iD, Gilles Peytavin, Mélanie Cresta, Charlotte Charpentier, Marc Digumber, Florence Damond, Yazdan Yazdanpanah iD, Sophie Matheron, Diane Descamps, Jade Ghosn iD

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciae447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Véronique Joly und 11 weiteren Autor:innen. Beteiligte Einrichtung: IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Service des Maladies Infectieuses et Tropicales, Hôpital Bichat Claude …. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Adenine, HIV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective study evaluated Bictegravir (BIC)/emtricitabine (FTC)/tenofovir alafenamide (TAF) in 24 persons with human immunodeficiency virus type 2 (HIV-2, PWHIV-2), 5 naive and 19 pretreated. After a median follow-up of 37.5 months, all PWHIV-2 had a plasma viral load <40 copies/mL. Median CD4 count increased significantly from 580 to 625 cells/mm3, suggesting the effectiveness of BIC/FTC/TAF to treat HIV-2 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-HIV AgentsAdenineHIV-2Heterocyclic Compounds, 4 or More RingsHumansRetrospective StudiesMaleAdultMiddle AgedEmtricitabineFemaleViral LoadTenofovirCD4 Lymphocyte CountPyridonesAlanineFollow-Up StudiesPiperazinesTreatment OutcomeHeterocyclic Compounds, 3-RingDrug CombinationsAmides

Substanzen

EmtricitabineAnti-HIV AgentsTenofovirAdeninebictegravirPyridonestenofovir alafenamideAlanineHeterocyclic Compounds, 4 or More RingsPiperazines

Autor:innen und Institutionen

  • IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Service des Maladies Infectieuses et Tropicales, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
  • IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP Laboratoire de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
  • IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Laboratoire de Pharmacologie-Toxicologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

ORCID-Profile: Véronique Joly, Quentin Le Hingrat, Yazdan Yazdanpanah, Jade Ghosn

Zitieren

APA

Joly, V., Ferré, V. M., Le Hingrat, Q., Peytavin, G., Cresta, M., Charpentier, C., Digumber, M., Damond, F., Yazdanpanah, Y., Matheron, S., Descamps, D., & Ghosn, J. (2025). Immuno-virological and Clinical Follow-up of Persons With HIV-2 (PWHIV-2) Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate (BIC/FTC/TAF): A Retrospective Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae447

Vancouver

Joly V, Ferré VM, Le Hingrat Q, Peytavin G, Cresta M, Charpentier C, et al. Immuno-virological and Clinical Follow-up of Persons With HIV-2 (PWHIV-2) Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate (BIC/FTC/TAF): A Retrospective Study. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciae447

BibTeX
@article{Joly2025,
  author = {Joly, Véronique and Ferré, Valentine M and Le Hingrat, Quentin and Peytavin, Gilles and Cresta, Mélanie and Charpentier, Charlotte and Digumber, Marc and Damond, Florence and Yazdanpanah, Yazdan and Matheron, Sophie and Descamps, Diane and Ghosn, Jade},
  title = {Immuno-virological and Clinical Follow-up of Persons With HIV-2 (PWHIV-2) Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate (BIC/FTC/TAF): A Retrospective Study},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciae447}
}
Kostenlos starten →